AVIRNasdaq

Atea Pharmaceuticals, Inc.

Pharmaceutical Preparations · MA · CIK 1593899

Develops and commercializes novel, orally administered antivirals for serious viral diseases like hepatitis C and E

$359M

Market cap

$4.61

Last close

+2.7%

+5.0%

516K

Volume

Price · last 39 sessions-19.1%

May 4L $4.10 · H $5.70Jun 29

Total filings

Jun 22, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance